Synthesis of New Thiazole‐Pyrazole Analogues: Molecular Modelling, Antiproliferative/Antiviral Activities, and ADME Studies
Chemical Biology & Drug Design · 2025-03 · 105 (3)
DOI: 10.1111/cbdd.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 14.03.2025. Verfasst von Hind A Siddiq und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Sciences, Chemistry Division, College of Science, Jazan University, Jazan, Saudi Arabia. Hauptthemen laut MEDLINE: Pyrazoles, Thiazoles, Cell Proliferation, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Twelve thiazole‐pyrazole analogues 4 , 6 , and 8 were synthesized by introducing various pyrazole systems into the core, 2‐((4‐acetylphenyl)amino)‐4‐methylthiazole ( 2 ), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge‐transfer (CT) may be denoted as π → π* and n → π*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc‐1, HT‐29, MCF‐7) and the non‐cancerous (WI‐38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc‐1 and MCF‐7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC 50 = 61 μg/μL), comparable to the reference drug amantadine (TC 50 = 72 μg/μL, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H‐bonding and π‐π stacking, with binding affinities between −4.8558 and − 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug‐like characteristics, but analogues 4a–d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Sciences, Chemistry Division, College of Science, Jazan University, Jazan, Saudi Arabia.
- Department of Medical Microbiology and Parasitology, Qunfudah Faculty of Medicine, Umm Al-Qura University, Al-Qunfudah, Saudi Arabia.
- Department of Pharmaceutical Science, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Biological Sciences/Microbiology, Faculty of Science, University of Jeddah, Jeddah, Saudi Arabia.
- Department of Physics, Faculty of Science, Taibah University, Madinah, Saudi Arabia.
- Department of Chemistry, College of Science, Qassim University, Buraidah, Saudi Arabia.
ORCID-Profile: Nashwa M El-Metwaly
Zitieren
APA
Siddiq, H. A., Imam, M. A., Alsharif, S. T., Attar, R. M. S., Almughathawi, R., Alshammari, N. M., Halawani, N. M., & El-Metwaly, N. M. (2025). Synthesis of New Thiazole‐Pyrazole Analogues: Molecular Modelling, Antiproliferative/Antiviral Activities, and ADME Studies. Chemical Biology & Drug Design, 105(3). https://doi.org/10.1111/cbdd.70090
Vancouver
Siddiq HA, Imam MA, Alsharif ST, Attar RMS, Almughathawi R, Alshammari NM, et al. Synthesis of New Thiazole‐Pyrazole Analogues: Molecular Modelling, Antiproliferative/Antiviral Activities, and ADME Studies. Chemical Biology & Drug Design. 2025;105(3). doi:10.1111/cbdd.70090
BibTeX
@article{Siddiq2025,
author = {Siddiq, Hind A and Imam, Mohammed A and Alsharif, Shaker T and Attar, Roba M S and Almughathawi, Renad and Alshammari, Nadiyah M and Halawani, Nuha M and El-Metwaly, Nashwa M},
title = {Synthesis of New Thiazole‐Pyrazole Analogues: Molecular Modelling, Antiproliferative/Antiviral Activities, and ADME Studies},
journal = {Chemical Biology & Drug Design},
year = {2025},
volume = {105},
number = {3},
doi = {10.1111/cbdd.70090}
}
EUVIMED